OR WAIT 15 SECS
© 2021 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Christen Harm is Pharmaceutical Executive's Associate Editor. Email her at charm@mmhgroup.com
Elaine Quilici is Pharmaceutical Executive's Senior Editor. Email her at equilici@mmh.com
Pharmaceutical Executive
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
Janice Kranz, co-founder of Eikonizo Therapeutics, bring us up to date on how targeting tau to fight Alzheimer’s and other neurodegenerative diseases is making waves in the CNS space.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
Pharmaceutical Executive Magazine
·
Episode 59: Using Tau to Target Alzheimer’s
Related Content: